Top Story

Tumor subtype provided prognostic factor for survival after WBRT for metastatic breast cancer

September 19, 2014

SAN FRANCISCO — Vipin Das Villgran, MD, medical resident at University of Pittsburgh Medical Center, discusses study results which found that tumor subtype predicted survival among patients with breast cancer who underwent whole-brain radiation therapy for brain metastases.

However, survival was not associated with tumor subtype among patients treated with stereotactic radiosurgery, results showed.

NIH director: Emerging biomedical research ‘breathtaking’

September 19, 2014
NIH director Francis Collins, MD, PhD, spoke to the audience at TEDMED 2014 about the advances in biomedical research on the horizon.“I have this amazing…
In the Journals

E-cigarettes emitted fewer carcinogenic particulates, higher toxic metals

September 19, 2014
Secondhand smoke from electronic cigarettes contained significantly fewer organic carcinogen emissions than tobacco-containing cigarettes, according to recent…
figure

UPenn, Wistar Institute to collaborate on $12 million SPORE grant

September 19, 2014
The Wistar Institute has announced that Meenhard Herlyn, DVM, DSc, will be the principal investigator on a $12.1 million…
More News Headlines »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
figure

Tumor subtype provided prognostic factor for survival after WBRT for metastatic breast cancer

September 19, 2014
SAN FRANCISCO — Vipin Das Villgran, MD, medical resident at University of Pittsburgh Medical Center, discusses…
More »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »